Search

Mirati Therapeutics Inc

Open

SectorGezondheidszorg

0

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

-0.05% downside

Nieuwssentiment

By Acuity

50%

50%

118 / 339 Rangschikking in Healthcare

Mirati Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 sep 2026, 23:56 UTC

News

EUR/GBP rises as Germany's business expectations for September exceed forecasts, reaching 90.4 and indicating notable strength in today's performance.

24 sep 2026, 23:55 UTC

News

LPL Financial reported total client assets of $2.60 trillion for August 2026, with the stock trading modestly lower in after-market hours.

24 sep 2026, 23:55 UTC

News
Social Media

MGM Resorts International shares are modestly lower in after-market trading as it considers a bid for People Incorporated amid uncertain negotiations.

24 sep 2026, 23:50 UTC

News

Regenxbio Inc. shares rose in after-market trading following positive three-year data for suragene lomparvovec, showing significant improvement in diabetic retinopathy patients.

24 sep 2026, 23:46 UTC

News

Pentair PLC shares are trading lower in after-market hours amid a securities class action lawsuit alleging false statements about inventory issues affecting sales.

24 sep 2026, 23:45 UTC

News

Global Payments Inc. is trading roughly flat in after-market hours, positioned below its 20-day moving average amid the Fed's announcement on cross-border transaction support.

24 sep 2026, 23:45 UTC

News

EUR/NOK is trading higher as Germany's business expectations for September exceeded forecasts at 90.4, compared to the previous 89.

24 sep 2026, 23:31 UTC

News

Celanese Corporation shares declined in after-market hours following the announcement of price increases for UHMW-PE and POM products, effective October 8, 2026.

24 sep 2026, 23:30 UTC

Event
News

Merck & Co Inc's stock traded modestly lower in after-market hours following the announcement of Phase 2b/3 BRUNELLO trial results for diabetic macular edema.

24 sep 2026, 23:21 UTC

News

CrowdStrike is collaborating with Snowflake to integrate its AI-native Falcon platform into the Snowflake Marketplace, with shares modestly higher in after-market trading.

24 sep 2026, 23:16 UTC

Correlated Moves
News

Rockwell Automation shares traded lower in after-market hours following the announcement of Chief Revenue Officer Scott A. Genereux's retirement and Wells Fargo's Equal Weight rating.

24 sep 2026, 23:16 UTC

News

EUR/JPY traded higher as Germany's September business expectations exceeded forecasts at 90.4, up from 89.3, contributing to modest gains in the currency pair.

24 sep 2026, 23:06 UTC

News

General Electric Co has secured a $199.7 million contract for the R-391 Propeller Assembly, with shares modestly higher in after-market trading.

24 sep 2026, 23:06 UTC

News

Wells Fargo analyst Joseph O'Dea initiated coverage on Otis Worldwide Corp with an Underweight rating, as shares traded roughly flat after market hours.

24 sep 2026, 23:06 UTC

Social Media
News

GameStop's shares are trading lower in after-market hours despite CEO Ryan Cohen's reported share purchases, influenced by a broader market decline.

24 sep 2026, 23:06 UTC

News
Event

Jabil Inc. shares are higher in after-market trading following a $1.7 billion contract manufacturing agreement with Akamai Technologies.

24 sep 2026, 23:06 UTC

News

Delta Air Lines declared a quarterly dividend of $0.2150 per share, while its shares are declining in after-market trading amid broader market trends.

24 sep 2026, 23:06 UTC

Social Media
News

Raises quarterly dividend to $1.17 per share

24 sep 2026, 23:06 UTC

News

EUR/NZD is trading slightly higher as Germany's business expectations for September exceeded forecasts, coming in at 90.4, above the previous reading of 89.

24 sep 2026, 23:06 UTC

Macro Event
News

The USD/NOK exchange rate is modestly higher, supported by lower U.S. initial jobless claims, reflecting recent macroeconomic developments.

24 sep 2026, 23:06 UTC

Correlated Moves
News

U.S. natural gas storage levels reached 53 billion cubic feet, surpassing forecasts, while USD/ZAR trades modestly higher amid correlated movements with USD/MXN.

24 sep 2026, 23:06 UTC

News

Newmont Corporation shares were roughly flat in after-market trading ahead of its Q3 2026 results announcement on October 22, 2026.

24 sep 2026, 23:05 UTC

News

Vertiv Holdings Co shares rose in after-market hours after Wells Fargo initiated coverage with an Overweight rating and a $340.00 price target.

24 sep 2026, 23:05 UTC

News

Automatic Data Processing Inc. is moving lower in after-market trading following the nomination of David W. Kenny and Nancy McKinstry to its Board of Directors.

24 sep 2026, 23:05 UTC

News

Northrop Grumman Corp is trading roughly flat in after-market hours as the U.S. Air Force seeks input for replacing outdated radar systems.

24 sep 2026, 23:01 UTC

News

nVent Electric PLC traded modestly lower in after-market hours following Wells Fargo's Equal Weight rating and $182.00 price target initiation by analyst Stephen Tusa.

24 sep 2026, 23:01 UTC

News

AeroVironment Inc is declining in after-market trading despite securing a $464.8 million U.S. Army contract for its Enduring High Energy Laser program.

24 sep 2026, 23:01 UTC

Social Media
News
Event

Costco reported fourth-quarter fiscal 2026 net sales of $93.9 billion and net income of $3.0 billion, exceeding expectations, with a slight increase in after-market trading.

24 sep 2026, 23:01 UTC

News
Event

Scholastic Corp reported a fiscal Q1 net loss of $71.2 million and revenues of $216.8 million, prompting a sharp decline in shares after-market hours.

24 sep 2026, 23:01 UTC

News

Starbucks plans to close about 250 locations, incurring $300 million in charges, while shares are modestly higher in after-market trading.

Peer Vergelijking

Prijswijziging

Mirati Therapeutics Inc Prognose

Koersdoel

By TipRanks

-0.05% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 58.67 USD  -0.05%

Hoogste 59 USD

Laagste 58 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Mirati Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

5 ratings

0

Buy

5

Hold

0

Sell

Sentiment

By Acuity

118 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

EBITDA

Operationele winst

$

Over Mirati Therapeutics Inc

Mirati Therapeutics, Inc. is a clinical-stage oncology company. It is focused on developing therapeutics to address the genetic and immunological promoters of cancer. Its clinical programs consist of product candidates, including Adagrasib (MRTX849), MRTX1133, and Sitravatinib. MRTX849 is an oral small-molecule therapy designed to shrink difficult-to-treat cancers harboring the KRAS G12C mutation. MRTX1133 is a small molecule-inhibitor of the KRASG12D mutation, designed to treat patients with unmet need. Sitravatinib is a spectrum-selective receptor tyrosine kinase (RTK) inhibitor that can stimulate the body’s immune response to fight cancer. MRTX849 is in Phase III and Phase I/II clinical trials and MRTX1133 is in preclinical development. Sitravatinib is in a Phase III clinical trial, and Phase I/II clinical trials. It also has additional preclinical discovery programs, which includes first-in-class and best-in-class product candidates designed to address mutations and tumors.